Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Anne-Marie
Anne Marie Degraff, Fort Lupton, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20110228911 | METHOD FOR DETERMINING TERMINATION OF AN EMERGENCY SERVICE CALL - A method for determining termination of an emergency service call; the emergency service call being connected with an emergency service answering entity in an emergency service network employing a locating unit for ascertaining a geographic origin for the emergency service call; the method including: (a) presenting a query signal from the emergency service answering entity during the emergency service call soliciting a responsive signal from the locating unit relating to the geographic origin; (b) if the query signal relating to the geographic origin is received by the locating unit, considering that the emergency service call is not terminated; and (c) if no query signal relating to the geographic origin is received by the locating unit, considering that the emergency service call is terminated. | 09-22-2011 |
Anne Marie Horneman, Humlebaek DK
| Patent application number | Description | Published |
|---|---|---|
| 20110190282 | NOVEL VEGF-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF - The invention relates to compounds of general formula (I) wherein W, D, E, G, J, L, R | 08-04-2011 |
| 20120028974 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES - The present invention relates to a compound according to formula I, wherein R | 02-02-2012 |
Anne Marie Isburgh, Cincinnati, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100153080 | Physics-Based Lifespan Modeling - An embodiment of a method for lifespan modeling for a turbine engine component includes determining a design-phase model of the lifespan of an turbine engine component; fusing the design-phase model with sensor data collected during operation of the turbine engine component to produce an updated model of the lifespan of the turbine engine component; and fusing the updated model with data collected during an inspection of the turbine engine component to produce an overall model of the lifespan of the turbine engine component. Systems for lifespan modeling for a turbine engine component are also provided. | 06-17-2010 |
Anne Marie Ryg, Mantorville, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080215535 | AUTONOMICALLY GENERATING A QUERY IMPLEMENTATION THAT MEETS A DEFINED PERFORMANCE SPECIFICATION - A database query optimizer allows specifying a performance specification for a query. When an access plan is created, the actual performance for executing the query using the access plan is determined and compared to the performance specification for the query. If the actual performance does not satisfy the performance specification for the query, the query optimizer autonomically generates a different access plan to see if the performance improves. If an access plan that meets the performance specification is generated, the new access plan is stored in the access plan cache for the query. If no access plan can be generated that meets the performance specification for the query, the access plan that provided the best performance is selected and stored in the access plan cache for the query. | 09-04-2008 |
| 20080215536 | AUTONOMICALLY GENERATING A QUERY IMPLEMENTATION THAT MEETS A DEFINED PERFORMANCE SPECIFICATION - A database query optimizer allows specifying a performance specification for a query. When an access plan is created, the actual performance for executing the query using the access plan is determined and compared to the performance specification for the query. If the actual performance does not satisfy the performance specification for the query, the query optimizer autonomically generates a different access plan to see if the performance improves. If an access plan that meets the performance specification is generated, the new access plan is stored in the access plan cache for the query. If no access plan can be generated that meets the performance specification for the query, the access plan that provided the best performance is selected and stored in the access plan cache for the query. | 09-04-2008 |
| 20080281779 | Query Directives And Access Plan Hints - A query plan modification system and method relate to a database system that includes a cost-based optimizer for generating access plans. The database system also permits a user to view an access plan that has been generated by a particular SQL query and modify the access plan if desired. The user specifies customizations that are associated with the access plan so that when that plan is executed, the customizations are executed as well. Exemplary customizations include specifying an initialization file specific to a query, specifying different implementation methods than those in the original access plan, prohibiting rebuilding of an access plan, and over-riding or ignoring a clause within the query that is used to generate the access plan. | 11-13-2008 |
| 20080281780 | Query Directives And Access Plan Hints - A query plan modification system and method relate to a database system that includes a cost-based optimizer for generating access plans. The database system also permits a user to view an access plan that has been generated by a particular SQL query and modify the access plan if desired. The user specifies customizations that are associated with the access plan so that when that plan is executed, the customizations are executed as well. Exemplary customizations include specifying an initialization file specific to a query, specifying different implementation methods than those in the original access plan, prohibiting rebuilding of an access plan, and over-riding or ignoring a clause within the query that is used to generate the access plan. | 11-13-2008 |
| 20090158091 | Intelligent Job Functionality - A method, apparatus, and program product utilize intelligent job functionality to diagnose an error in a computer. After detecting an error in a first job processing a task, and in response to another attempt to perform the task, a job selection algorithm selects a predetermined job in which to perform the task and diagnose the error. The predetermined job can be the first job or a new job associated with a signature that corresponds to the task that experienced the error. The predetermined job can be used to diagnose the error in a debugging session. Alternately, the first job may enter a debug session immediately after experiencing an error. | 06-18-2009 |
Anne Marie Smith, Anoaster CA
| Patent application number | Description | Published |
|---|---|---|
| 20120135437 | BIOSENSORS UTILIZING INK JET-PRINTED BIOMOLECULE COMPATIBLE SOL GEL INKS AND USES THEREOF - Novel solid-phase biosensors that utilize ink jet printing of biocompatible sol-gel based inks to create sensor strips are reported herein. Biomolecules and other reagents useful in bioassays to detect, for example, pathogenic microorganisms or toxic substances, are immobilized on a substrate, which can be paper based, by layering these substances between two layers of biomolecule compatible sol gel. The sol gel precursor solutions and solutions of the assay reagents are printed from separate nozzles in a layered approach which avoids clogging of the nozzles by the pre-mature gelling of the sol gel precursor solution. In certain embodiments of the application, a capture agent is used to concentrate a compound to be detected in specific areas on the substrate to facilitate detection. | 05-31-2012 |
Anne-Marie Baribeau, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20110053261 | METHODS FOR DETERMINING CORRELATED RESIDUES IN A PROTEIN OR OTHER BIOPOLYMER USING MOLECULAR DYNAMICS - The invention provides methods and systems of determining biopolymer profiles and correlations between structural units (residues) of a biopolymer based on sampling of the conformational space available to the molecule. The correlations between these structural units can further be used to find networks within a biopolymer such as the coupled residue networks in a protein. The invention also provides for designing and engineering biopolymers including polypeptides, nucleic acids and carbohydrates using the information derived from the conformation clustering and subsequent methods described herein. | 03-03-2011 |
Anne-Marie Birot, Sainte-Foy-Les-Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20090151013 | Modified ES cells and ES cell-specific genes - The invention concerns modified avian ES cells, specifically expressing an exogenous gene when they have a pluripotent character. The invention also concerns a nucleic acid and a polypeptide specifically expressed in pluripotent avian cells, and methods for detecting the pluripotent character of cells using said nucleic acid and polypeptide. | 06-11-2009 |
Anne-Marie Bonnot, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100154087 | METHOD FOR GROWING A CARBON NANOTUBE ON A NANOMETRIC TIP - The invention relates to a method for the catalytic growth of carbon nanotubes on nanometric tips by chemical vapour deposition assisted by a hot filament, that comprises a first step of applying a preliminary dual-layer coating of cobalt and titanium on said tip, the titanium layer having a thickness of between 0.1 nm and 0.2 nm and cobalt layer having a thickness of between 0.3 nm and 2 nm. | 06-17-2010 |
Anne-Marie Chaze, Nice FR
| Patent application number | Description | Published |
|---|---|---|
| 20110011310 | METHOD OF MANUFACTURING A COMPOSITE BASED ON COMPLEXES OF CONTROLLED STABILITY - The method for manufacturing a composite based on complexes of controlled stability over time using a fibrous inorganic matrix having tunnels and one or more organic compounds incorporated into said tunnels includes the following steps: the fibrous inorganic matrix having tunnels and the organic compound or compounds are provided; the fibrous inorganic matrix having tunnels is mixed with the organic compound or compounds so that said organic compound or compounds are incorporated into the tunnels of the fibrous inorganic matrix; the retention of the organic compound or compounds in said tunnels and their release therefrom by heating said mixture obtained, at a chosen temperature for a defined time, are controlled. The invention applies in particular in a preparation intended for cosmetic, pharmacological, nutri-therapeutic and agri-foodstuff, phytosanitary, petroleum or electronic usage or else in paints. | 01-20-2011 |
Anne-Marie Doisy, Joinville Sur Juine FR
| Patent application number | Description | Published |
|---|---|---|
| 20110094470 | COMBUSTION ENGINE COMBUSTION CHAMBER - A piston for an internal combustion engine, for example a diesel engine, including a body delimited laterally by a skirt and configured to collaborate with walls of a cylinder of axis of revolution C in which the piston can slide along the axis C, the piston including a transverse face including a central pip, a peripheral ring, and a bowl of axis of revolution B that extends from the central pip towards the peripheral ring to which it connects at a lip of thickness Ep, the bowl including, in substantial vertical alignment with the lip, a torus in profile, for example of dome-shaped, of maximum radius capable of guiding fuel injected under the lip in the region of a re-entrant zone towards the central pip. The tip of the central pip exhibits a flattened region centred on the axis of revolution B of the bowl, of a width Lt ranging between 0 mm and 5 mm, or substantially equal to 2.5 mm. | 04-28-2011 |
Anne-Marie Duliege, Palo Alto, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090118183 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. | 05-07-2009 |
| 20090136442 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. | 05-28-2009 |
| 20090209457 | TREATMENT OF ANTI-ERYTHROPOIETIN ANTIBODY-MEDIATED DISORDERS WITH SYNTHETIC PEPTIDE-BASED EPO RECEPTOR AGONISTS - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat or to prevent anti-erythropoietin (EPO) antibody-mediated disorders such as pure red cell aplasia (PRCA) that are characterized by anti-EPO antibodies. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided. | 08-20-2009 |
| 20090221510 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to novel uses of peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to methods of using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production, including chemotherapy induced anemia. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided. Also provided are kits and articles of manufacture comprising such compounds. | 09-03-2009 |
Anne-Marie Frelin, Caen FR
| Patent application number | Description | Published |
|---|---|---|
| 20110186740 | SYSTEM FOR CONTROLLING PHOTOMULTIPLIER GAIN DRIFT AND ASSOCIATED METHOD - A system for controlling photomultiplier gain drift is disclosed. According to one aspect, the system includes first means for measuring a noise signal of the photomultiplier, the first means configured emit a measurement signal representative of the photomultiplier's noise signal. The system further includes second means for maintaining the measured noise signal at a constant level, based on the measurement signal. The disclosed embodiments apply to stabilization of the gain of photomultipliers and, more specifically, to stabilization of neutron measurement systems using photomultipliers. | 08-04-2011 |
Anne-Marie Goethals, Oud-Heverlee BE
| Patent application number | Description | Published |
|---|---|---|
| 20080229273 | SYSTEMS AND METHODS FOR UV LITHOGRAPHY - A method of designing a lithographic mask for use in lithographic processing of a substrate is disclosed. The lithographic processing comprises irradiating mask features of a lithographic mask using a predetermined irradiation configuration. In one aspect, the method comprises obtaining an initial design for the lithographic mask comprising a plurality of initial design features having an initial position. The method further comprises applying at least one shift to at least one initial design feature and deriving there from an altered design so as to compensate for shadowing effects when irradiating the substrate using a lithographic mask corresponding to the altered design in the predetermined irradiation configuration. Also disclosed herein are a corresponding design, a method of setting up lithographic processing, a system for designing a lithographic mask, a lithographic mask, and a method of manufacturing it. | 09-18-2008 |
| 20080315125 | METHOD AND SYSTEM FOR MEASURING CONTAMINATION OF A LITHOGRAPHICAL ELEMENT - A method and system for measuring contamination of a lithographic element is disclosed. In one aspect, the method comprises providing a first lithographical element in a process chamber. The method further comprises providing a second lithographical element in the process chamber. The method further comprises covering part of the first lithographical element providing a reference region. The method further comprises providing a contaminant in the process chamber. The method further comprises redirecting an exposure beam via the test region of the first lithographical element towards the second lithographical element whereby at least one of the lithographical elements gets contaminated by the contaminant. The method further comprises measuring the level of contamination of the at least one contaminated lithographical element in the process chamber. | 12-25-2008 |
| 20090103069 | DETECTION OF CONTAMINATION IN EUV SYSTEMS - A sensor for sensing contamination in an application system is disclosed. In one aspect, the sensor comprises a capping layer. The sensor is adapted to cause a first reflectivity change upon initial formation of a first contamination layer on the capping layer when the sensor is provided in the system. The first reflectivity change is larger than an average reflectivity change upon formation of a thicker contamination layer on the capping layer and larger than an average reflectivity change upon formation of an equal contamination on the actual mirrors of the optics of the system. | 04-23-2009 |
| 20120099092 | DETECTION OF CONTAMINATION IN EUV SYSTEMS - A sensor for sensing contamination in an application system is disclosed. In one aspect, the sensor comprises a capping layer. The sensor is adapted to cause a first reflectivity change upon initial formation of a first contamination layer on the capping layer when the sensor is provided in the system. The first reflectivity change is larger than an average reflectivity change upon formation of a thicker contamination layer on the capping layer and larger than an average reflectivity change upon formation of an equal contamination on the actual minors of the optics of the system. | 04-26-2012 |
Anne-Marie Gue, Rebigue FR
| Patent application number | Description | Published |
|---|---|---|
| 20090200165 | USE OF POLYMER REAGENTS TO MODULATE AND CONTROL ELECTROKINETIC FLOWS IN A MICRO- OR NANOFLUIDIC DEVICE - The invention concerns the field of microfluidics and in particular that of electrophoresis on a micro- or nanofluidic device. More particularly, the invention concerns the use of a reactive polymer coating adapted to be submitted to a phase separation under the influence of an external stimulation of chemical or physical type, to modulate the electrokinetic flows (electroosmotic or electrophoretic flows during electrophoresis for example) in a micro- or nanofluidic device. The invention also concerns a method for varying the electrokinetic flows in such a device using said coating, as well as the micro- or nanofluidic devices comprising at least one channel or one capillary tube whereof the inner surface is covered at least partly with such a coating. | 08-13-2009 |
Anne-Marie Lezoray, Villeconin FR
| Patent application number | Description | Published |
|---|---|---|
| 20100285076 | FLUID COSMETIC COMPOSITION COMPRISING A MONOALCOHOL - The present invention relates to the field of making up and/or caring for the skin and is targeted in particular at providing a fluid care and/or make-up cosmetic composition in the form of a water-in-oil emulsion dedicated to the skin comprising a fatty phase, an aqueous phase and at least one dimethicone copolyol, the aqueous phase forming 40 to 60% by weight, with respect to the total weight of the said composition, and comprising at least 5% by weight, with respect to the total weight of the composition, of at least one C | 11-11-2010 |
Anne-Marie Lienhardt, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20110241591 | DEVICE WITH A POLYPHASE ELECTRICAL MACHINE, AND RELATED ELECTRICAL MACHINE - The invention relates to a device having a polyphase electrical machine, wherein a plurality of inverters ( | 10-06-2011 |
Anne-Marie Lompre, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110150862 | INHIBITORS OF STIM1 FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS - The invention relates to inhibitors of STIM1 for the treatment and/or the prevention of cardiac disorders such as atherosclerosis, post-angioplasty restenosis, pulmonary arterial hypertension, vein-graft disease, cardiac hypertrophy, cardiac arrhythmias, valvulopathies, diastolic dysfunction, chronic heart failure, ischemic heart failure, and myocarditis. | 06-23-2011 |
| 20110218232 | Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders - The invention relates to inhibitors of Multi drug Resistant Protein 4 (MRP4) for the treatment and/or the prevention of cardiac disorders, such as acute or chronic heart failure and cardiogenic shock. The invention also relates to agents stimulating MRP4 activity for the treatment and/or the prevention of cardiac hypertrophy. | 09-08-2011 |
Anne-Marie Lompre, Evry FR
| Patent application number | Description | Published |
|---|---|---|
| 20100278809 | Inhibitors of MRP4 for the Treatment of Vascular Disorders - The invention relates to inhibitors of MRP4 for the treatment and/or the prevention of vascular disorders such as atherosclerosis, post-angioplasty restenosis, pulmonary arterial hypertension or vein-graft disease. | 11-04-2010 |
Anne-Marie Mariotte, Saint Simeon De Bressieux FR
| Patent application number | Description | Published |
|---|---|---|
| 20110237551 | Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions - The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: | 09-29-2011 |
Anne-Marie Meadon, Midrand ZA
| Patent application number | Description | Published |
|---|---|---|
| 20110173976 | ENERGY GENERATING SYSTEM USING A PLURALITY OF WATERWHEELS - An energy generating system is provided, comprising a primary waterwheel for receiving water from a head penstock or upper pumping setup, the primary waterwheel comprising a plurality of radial arms rotatable about a primary axis, the radial arms terminating in water scoops for accommodating the water from the head penstock or upper pumping setup, the primary waterwheel defining head height. The system further comprises at least one additional waterwheel located within the head height of the primary waterwheel, the additional waterwheel also comprising a plurality of radial arms rotatable about an axis, the radial arms terminating in water scoops for accommodating either excess water from the head penstock or upper pumping setup or water that has spilled out of the water scoops of the primary waterwheel. In an example embodiment, the primary waterwheel and the at least one additional waterwheel are vertically orientated. In an example embodiment, the at least one additional waterwheel is smaller than the primary waterwheel. | 07-21-2011 |
Anne-Marie Mes-Masson, Dollard Des Ormeaux CA
| Patent application number | Description | Published |
|---|---|---|
| 20080248501 | Methods of Diagnosing Ovarian Cancer and Kits Therefor - A method for the diagnosis of ovarian cancer comprising providing a biological sample from a subject (subject sample), and detecting the expression level of each of the markers FGF-2, CA 125 and IL-18 in the subject sample A kit comprising means for detection of an expression level of each of the markers CA 125, FGF-2 and IL-18 in a biological sample from a subject (subject sample), and instructions to use said markers in a method of the present invention. | 10-09-2008 |
| 20090123932 | QUANTITATIVE TEST TO DETECT DISEASE PROGRESSION MARKERS OF EPITHELIAL OVARIAN CANCER PATIENTS - The present invention concerns a method of prognosing the risk of early ovarian cancer relapse in a subject having ovarian cancer comprising: a) detecting the level of at least one marker selected from the group consisting of BTF4, GCS and HLA-DRbeta1; and b) comparing the level of the above at least one marker with that of a corresponding control sample, wherein the detection of a lower level of the at least one marker compared to that in the control sample is indicative that the subject is at risk of early cancer relapse. Also provided is a method of stratifying a subject suffering from ovarian cancer based on the expression levels of the disclosed markers and kits for practicing the methods of the present invention. | 05-14-2009 |
Anne-Marie Praden, Ventabren FR
| Patent application number | Description | Published |
|---|---|---|
| 20080271103 | Controlling Access to Broadcast Services in a Terminal Device - Services are distributed via a distribution network to terminal devices. One of the services is an electronic service guide stored in the terminal devices and providing descriptive data on the distributed services. To control access to the services distributed to a terminal device, the device includes a module for filtering descriptive data on the distributed services in accordance with at least one filtering criterion, and a graphics module for displaying the filtered descriptive data that meets the filtering criterion so as to enable services associated with the displayed filtered descriptive data to be selected. | 10-30-2008 |
| 20090328099 | BROADCAST SYSTEM WITH A LOCAL ELECTRONIC SERVICE GUIDE GENERATION - A broadcast system includes a terminal system having a display module for displaying an Electronic Service Guide (ESG) of programs to be broadcasted. The ESG initiates the storing of a program selected through such ESG and broadcasted to the terminal system. The broadcast system includes a module for creating and displaying a local ESG on the terminal system. This local ESG corresponds to programs which have been selected, broadcasted and stored in the terminal system. The local ESG launches the rendering of a stored program in response to actuating a corresponding item in the local ESG. | 12-31-2009 |
| 20100306795 | SUBSCRIBER IDENTITY MODULE AND ASSOCIATED BROADCASTING SERVER ADAPTED FOR MANAGING PROGRAMS HAVING UNDEFINED DURATION - The invention relates to a value-added service applied to the broadcasting of video programs or content and more particularly to mobile television (Mobile TV). The invention promotes service continuity during the broadcasting of programs having an undefined duration and the broadcasting of which has been subject to a Pay-Per-View type purchase. | 12-02-2010 |
| 20100319022 | PERSONALIZED VIDEO SEGMENT IN BROADCAST WORLD - A personal mobile TV system (T, CP) stores an end-user profile, and it stores and runs a content personalization program controlling the system into automatic selection of a video segment source (BN | 12-16-2010 |
| 20110185377 | METHOD FOR ACCESSING A SERVICE OFFERED FROM A TOKEN, CORRESPONDING TOKEN AND SYSTEM - The invention relates to a method for accessing a service offered from a token. The token is coupled with a terminal. The terminal is capable of receiving broadcast messages. The messages are broadcasted from at least one server. According to the invention, the server sends, through the terminal, within the broadcast messages, at least one piece of data intended for the token and executable by the token. The token executes the executable data by triggering an execution of an application embedded at least in part within the token. The invention relates also to a corresponding token and system. | 07-28-2011 |
Anne-Marie Praden, Ventabrent FR
| Patent application number | Description | Published |
|---|---|---|
| 20090006584 | Service Personalization in a Terminal Device - Two service signals are transmitted from a service server through a first network in such a way that users' terminal devices display personalized service data items. When service signals are filtered, a terminal device extracts common data items accessible for several terminal devices and a parameter type from a service signal identified by a stored identifier. An end address is determined by applying a stored parameter, related to the parameter type, to a pre-recorded or transmitted algorithm. The end address is transmitted, through a second network, to a server which transmits a first personalized file associated with the end address and bearing personalized data items displayed with the common data items in the device. | 01-01-2009 |
Anne-Marie Prins, Herselt BE
| Patent application number | Description | Published |
|---|---|---|
| 20090264567 | Stabilized Cross-Linked Polyolefin Compositions - A composition is disclosed that includes at least one polyolefin, at least one organic peroxide, and an antioxidant mixture of a composition of at least one polyolefin, at least one organic peroxide, and an antioxidant mixture. The antioxidant mixture has at least one fast radical scavenger selected from the group consisting of low hindered phenols, low hindered thiophenols, low hindered thiobisphenols, aliphatic amines, aromatic amines, NOR HALS, hydroxylamines, and mixtures thereof, and at least one long term stabilizer selected from the group consisting of low hindered phenols, highly hindered phenols, thiosynergists, aliphatic amines, aromatic amines, HALS, hydroxylamines, and mixtures thereof. The preferred polyolefin is a homopolymer of ethylene or a copolymer of ethylene and the compositions are useful in insulating media for medium and high voltage wire and cable applications. | 10-22-2009 |
Anne-Marie Pulichino, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110263681 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 10-27-2011 |
| 20120115933 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-10-2012 |
| 20120115934 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-10-2012 |
| 20120122960 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-17-2012 |
Anne-Marie Rasmussen, Oslo NO
| Patent application number | Description | Published |
|---|---|---|
| 20100068193 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 03-18-2010 |
| 20100129340 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 05-27-2010 |
Anne-Marie Riquet, Gif Sur Yvette FR
| Patent application number | Description | Published |
|---|---|---|
| 20100210725 | COPOLYMER-GRAFTED POLYOLEFIN SUBSTRATE HAVING ANTIMICROBIAL PROPERTIES AND METHOD FOR GRAFTING - A method for grafting a copolymer onto a polyolefin substrate includes the following steps: | 08-19-2010 |
Anne-Marie Schmitt-Milas, Tournefeuille FR
| Patent application number | Description | Published |
|---|---|---|
| 20090239934 | Anti-Myosin Va siRNA and Skin Depigmentation - The present invention relates to novel isolated siRNAs comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, characterized in that the sense RNA strand comprises a sequence which has at most one nucleotide that is distinct in relation to a fragment of 14 to 30 contiguous nucleotides of the nucleotide sequence of exon F of the gene encoding the myosin Va protein, and also to compositions comprising at least one such siRNA, and to the use of at least one such siRNA as a cosmetic or therapeutic agent for skin depigmentation. | 09-24-2009 |
Anne-Marie Stomp, Moncure, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090282584 | EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEED - Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. | 11-12-2009 |
Anne-Marie Templeman, Minyip AU
| Patent application number | Description | Published |
|---|---|---|
| 20110043014 | CAR SEAT FOR A CHILD - The invention concerns a child seat for a car with a rear passenger seat that divides a passenger cabin space and a rear storage space and that is foldable to provide access to the rear storage space from the passenger cabin space. The child seat comprises a seat for a child and a mounting that links the seat to the car. The mounting is operable to transfer the seat between the rear storage space and the passenger space for storage and for carrying a child, respectively. | 02-24-2011 |
Anne-Marie Tousch, Colombes FR
| Patent application number | Description | Published |
|---|---|---|
| 20100066761 | METHOD OF DESIGNATING AN OBJECT IN AN IMAGE - The present invention relates to a method of designating an object in an image. The method includes: designating a point inside the object in the image; segmenting the image into elementary regions; identifying an origin region to which the point belongs; constructing a graph of connectedness between the regions; calculating a function of membership in the object for the regions connected to the origin region, by combining various membership criteria; merging the origin region with its connected regions, a connected region being merged if the value of its membership function is greater than a predetermined threshold; wherein the steps of calculating membership functions of the connected regions and of merging is repeated for each new merged region until no merging is performed. One or more embodiments of the invention applies to image processing in order to perform the graphical designation of an object by an operation that is simple for a user. | 03-18-2010 |
Anne-Marie Ulmer-Moll, Rennes FR
| Patent application number | Description | Published |
|---|---|---|
| 20090129490 | Method and a Device for Dynamically Selecting Orthogonal Functions of an Orthogonal Transmission System - An interleaving method ( | 05-21-2009 |
| 20090274035 | Dynamic Interleaving Method and Device - An interleaving method ( | 11-05-2009 |
| 20100008214 | Interleaving with iterative calculation of interleaving addresses - A method and a device ( | 01-14-2010 |
| 20110002323 | DYNAMIC TIME INTERLEAVING METHOD AND AN ASSOCIATED DEVICE - The present invention relates to a time interleaving method ( | 01-06-2011 |
Anne-Marie Vissac, Neuville Sur Oise FR
| Patent application number | Description | Published |
|---|---|---|
| 20100015647 | METHOD AND KIT FOR THE DETECTION OF HEPARIN-DEPENDENT ANTIBODIES AND THE DIAGNOSIS OF IMMUNE OR AUTOIMMUNE PAHTOLOGIES POTENTIATED BY HEPARIN SUCH AS HEPARIN-INDUCED THROMBOCYTOPENIA - The invention relates to a method for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by a heparin substance, such as thrombocytopenia induced by heparin (HIT type II) as inducer drug. The invention is characterized in that said method comprises the steps consisting in: 1) reacting: at least one substance with high affinity for a heparin substance (SFA), consisting of any molecule or complex having a high affinity for a heparin substance, with at least one heparin substance (SH) so as to form a substance with high affinity for heparin-heparin substance (SFA-SH) complex, wherein the heparin substance is in slight or large excess, so as to be able to bind other substances with affinity for heparin; then with at least one potential antigenic substance capable of reacting with the heparin substance, thus forming a complex (Ag-SH; and, finally, with the plasma or the serum of a patient to be tested (preferably diluted to a dilution of the order of 1:100) potentially containing: an anti(Ag-SH) antibody material generated in the organism after administration of a heparin substance, and/or at least one immune complex consisting of an Ag-SH/anti(Ag-SH) antibody complex present in the plasma or serum of the patient capable of reacting with the substance with high affinity for the heparin substance-heparin substance (SFA-SH) complex, and then, 2) revealing the resulting (Ag-SH)-anti(Ag-SH) complex produced. | 01-21-2010 |
Anne-Marie Zuurmond, Den Haag NL
| Patent application number | Description | Published |
|---|---|---|
| 20100035271 | Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions - The present invention relates to the gene PLOD2 which codes for telopeptide lysyl hydroxylase (TLH). This enzyme converts telopeptidyl Lys into telopeptidyl Hyl, that can subsequently be converted into hydroxyallysine cross-links. Collagen with hydroxyallysine cross-links shows a higher resistance to degradation by proteinases than collagen with cross-links derived from allysine. | 02-11-2010 |